SURAKSHA326.20

Suraksha Diagnostic Limited

· Pharma & Health
₹ CrorePeersKRSNAAHEALTHXNEPHROPLUS3BBLACKBIOMcap ₹1,699 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation35.341.4
+ Impairment Loss / (Reversal)2.20.5
+ Finance Costs8.412.6
+ Interest Income-3.2-2.3
+ Fair Value (Gains) / Losses0.20.0
+ Share-based Payments0.00.9
+ Other Non-cash Items0.0-0.4
Changes in Working Capital
+ Inventories-1.4-0.1
+ Trade Receivables — Current-7.2-9.2
+ Other Financial Assets — Non-current-3.1-0.1
+ Other Current Assets-1.3-2.0
+ Trade Payables — Current0.07.4
+ Other Financial Liabilities — Current0.91.5
+ Other Current Liabilities1.6-0.2
+ Provisions — Current0.10.6
Cash from Operating Activities
Profit Before Tax (per I/S)41.444.649.5
+ Total Adjustments (incl. Working Capital)32.550.6
Cash from Operations (pre-tax)73.995.2
+ Income Taxes Paid10.613.4
Cash from Operating Activities63.481.8
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)42.067.3
+ Disp of Fixed Assets0.10.1
+ Acq of Subsidiaries / Businesses (net)1.03.3
+ Interest Received — Investing3.62.6
+ Other Inflows / (Outflows) — Investing-0.315.7
Cash from Investing Activities-39.6-52.2
Cash from Financing Activities
+ Proceeds from Borrowings-2.80.1
+ Repayment of Borrowings0.04.4
+ Payment of Lease Liabilities20.724.1
+ Interest Paid0.60.3
+ Other Inflows / (Outflows) — Financing0.10.0
Cash from Financing Activities-24.0-28.7
Net Changes in Cash (pre-FX)-0.31.0
Net Changes in Cash-0.31.0
Reference Items
EBITDA81.295.4102.1
EBITDA Margin %32.2330.7331.58
Free Cash Flow (CFO − Capex)21.314.514.5
Free Cash Flow to Equity10.1
Free Cash Flow per Basic Share4.102.782.78
Price to Free Cash Flow117.29
Cash Flow to Net Income2.052.61
Cash Paid for Taxes10.613.4
Cash Paid for Interest0.60.3
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.